Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Drug Interaction Liability of Kratom
NCT04392011Phase 1Completed
- Sponsor
- Washington State University
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Washington State University. Primary endpoint: Midazolam Area Under the Concentration vs. Time Curve at 144 hours. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT04392011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392011.